Envestnet Portfolio Solutions
ABBV icon

Envestnet Portfolio Solutions’s AbbVie ABBV Stock Holding History

Envestnet Portfolio Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5M Buy
89,324
+6,327
+8% +$1.36M 0.11% 117
2026
Q1 		$18.1M Sell
82,997
-48,455
-37% -$10.7M 0.1% 120
2025
Q4 		$30M Buy
131,452
+5,714
+5% +$1.3M 0.11% 106
2025
Q3 		$29.1M Sell
125,738
-3,733
-3% -$760K 0.11% 103
2025
Q2 		$24M Sell
129,471
-13,330
-9% -$2.48M 0.09% 112
2025
Q1 		$29.9M Sell
142,801
-55,876
-28% -$10.9M 0.11% 97
2024
Q4 		$35.3M Sell
198,677
-3,720
-2% -$684K 0.12% 94
2024
Q3 		$40M Buy
202,397
+3,214
+2% +$600K 0.13% 84
2024
Q2 		$34.2M Buy
199,183
+7,614
+4% +$1.26M 0.12% 94
2024
Q1 		$34.9M Buy
191,569
+19,828
+12% +$3.42M 0.13% 90
2023
Q4 		$26.6M Buy
171,741
+15,685
+10% +$2.29M 0.11% 103
2023
Q3 		$23.3M Buy
+156,056
New +$22.9M 0.11% 103

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Envestnet Portfolio Solutions's ABBV Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its AbbVie (ABBV) stake by 7.6% in Q2 2026, buying an estimated $1.36M and bringing the position to 89,324 shares worth $22.5M. The position accounts for 0.11% of the portfolio, ranked #117.

Envestnet Portfolio Solutions first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. The position peaked at $40M in Q3 2024. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Envestnet Portfolio Solutions held 89,324 shares of AbbVie worth $22.5M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 6,327 AbbVie shares in Q2 2026, an estimated $1.36M.
  • AbbVie made up 0.11% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #117 holding.
  • Envestnet Portfolio Solutions first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's AbbVie position peaked at $40M in Q3 2024.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.